S&P 500 Consumer Staples Sector SEC Filings — March 23, 2026

23-03-2026

Technology & Telecommunication Acquisition Corp (TETE) has filed a DEFM14A proxy statement dated March 23, 2026, for an extraordinary general meeting on or after the record date of February 25, 2026, to approve a Business Combination with Super Apps and Holdings, resulting in PubCo listing on Nasdaq as RADB, subject to approval. Post-merger ownership remains stable across minimum, mid-point, and maximum redemption scenarios, with Holdings shareholders at 85.3-85.4% (basic) or 58.4% (fully diluted), Sponsor at 10.7%/9.3%, and public shareholders at a low 1.6-1.7%/29.7%; a $5.0M PIPE is committed (with $16.0M interest), but the trust account holds only $142,275.91 as of February 23, 2026, signaling potentially high redemptions. The merger will make PubCo a controlled company with Bradbury Private Investment XVIII holding 34.5% voting power, and includes Sponsor forfeitures of 447,952 shares and contingent shares to MobilityOne.

• ·Non-Redemption Agreements dated January 19, 2025 (150,000 shares forfeited) and April 14, 2025 (297,952 shares forfeited), terminated but forfeiture obligation survives.
• ·TETE incorporated November 8, 2021; Class A shares, warrants, units listed on OTC Pink Current January 23, 2025 under TETEF, TETWF, TETUF.
• ·Nasdaq listing approval for RADB is a closing condition, waivable by Holdings and Super Apps.
• ·Shareholder meeting requests for additional documents by March 19, 2026.

23-03-2026

Richmond Mutual Bancorporation, Inc. (RMBI) and The Farmers Bancorp, Frankfort, Indiana entered into a merger agreement on November 11, 2025, pursuant to which Farmers Bancorp will merge into RMBI, creating a combined bank holding company with approximately $2.6B in total assets and 25 branches across Indiana and Ohio. Farmers Bancorp shareholders will receive 3.40 shares of RMBI common stock per share (exchange ratio), valued at approximately $44.71 per share or $82.4M aggregate based on RMBI's closing price on the announcement date, with former Farmers shareholders owning ~38% of the combined company post-merger. The transaction is subject to shareholder approval at meetings in 2026 and includes standard risks such as potential changes in RMBI stock value.

• ·Merger agreement dated November 11, 2025; S-4 filing date March 23, 2026.
• ·RMBI trades on NASDAQ under 'RMBI'; Farmers Bancorp on OTC Pink under 'FABP'.
• ·Merger expected to qualify as tax-free reorganization under IRC Section 368(a), except for cash in lieu of fractional shares.
• ·Shareholder meetings: RMBI annual meeting and Farmers Bancorp special meeting scheduled for [·], 2026.
• ·I.R.S. Employer Identification No. for RMBI: 36-4926041.

23-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 23, 2026, announcing the issuance of a press release regarding the integration of RAD devices into the Immix platform by AITX's RAD and Immix entities. No financial metrics, performance comparisons, or quantitative impacts were disclosed in the filing.

23-03-2026

CECO Environmental Corp. presented at the 38th Annual Roth Conference on its proposed merger with Thermon Group Holdings, Inc., offering $10 cash per Thermon share plus 0.684 CECO shares, with expected cost synergies >$40M (75% by end-2027) and ~2.5x net leverage at close. CECO standalone delivered FY25 revenue of $774M (up ~39% YoY from $558M) and Adjusted EBITDA of $90M (up ~43% YoY from $63M), though gross profit margins remained flat at 35%; FY26 guidance raised to $925-975M revenue (+23% YoY midpoint) and $115-135M Adjusted EBITDA (+38% YoY midpoint) on a $6.5B+ pipeline. The deal requires shareholder and regulatory approvals amid risks including integration challenges and potential failure to achieve synergies.

• ·CECO cumulative stock return ~700% since March 2020 vs. S&P 500 ~73% and Russell 2000 ~24%.
• ·Pipeline growth ~430% since full year 2021; orders ~415% and revenue ~290%.
• ·End-market mix FY25E: 50% highly engineered, 25% standard/lightly engineered, 25% short cycle/parts/aftermarket.
• ·CECO stock price $55.28 as of March 20, 2026 close.

23-03-2026

PMGC Holdings Inc. (ELAB) entered into Amendment No. 5 on March 17, 2026, to its consulting agreement with GB Capital Ltd (wholly owned by CEO/CFO/Director Graydon Bensler), setting the annual consultant fee at $300,000 effective January 1, 2026. The company also entered into a similar Amendment No. 5 with Northstrive Companies Inc. (wholly owned by Chairman Braeden Lichti), setting the annual fee at $360,000 effective the same date. These amendments restate fee provisions of prior agreements originally dated October 25, 2024, with no other changes.

• ·Original consulting agreements dated October 25, 2024
• ·Prior amendments dated April 3, 2025; August 12, 2025; October 16, 2025
• ·Filing date: March 23, 2026

23-03-2026

Honeywell International Inc. announced the results as of March 19, 2026, and pricing for its tender offers to purchase certain existing debt securities, with settlement expected on March 24, 2026. Upon settlement, the special mandatory redemption obligation on $10B aggregate principal amount of Honeywell Aerospace senior notes (including $1.25B 3.900% due 2028, $1.25B 4.000% due 2029, and others up to 4.950% due 2036) will cease. This supports the planned Spin-Off of Honeywell Aerospace Inc.

• ·Tender offer results cutoff: 5:00 p.m. New York City time on March 19, 2026.
• ·Press releases on tender offer results (Exhibit 99.1) and pricing (Exhibit 99.2) dated March 20, 2026.
• ·Honeywell common stock and various senior notes traded on Nasdaq Stock Market LLC.

23-03-2026

AMERICAN REBEL HOLDINGS INC (formerly CUBESCAPE INC) filed an 8-K on March 23, 2026, covering Items 3.03 (material modifications to rights of security holders), 5.03 (charter or bylaws amendments), 7.01 (Regulation FD disclosure), and 9.01 (financial statements and exhibits). The filing is categorized under Charter/Bylaws Amendments as a material event, with no quantitative financial data, period-over-period comparisons, improvements, declines, or flat performance disclosed in the provided metadata. No additional positive or negative metrics are available.

• ·Company CIK: 0001648087
• ·SIC: 3490 - MISCELLANEOUS FABRICATED METAL PRODUCTS
• ·State of Incorporation: NV; Location: TN; Fiscal Year End: December 31
• ·Mailing/Business Address: 218 3RD AVENUE NORTH, #400, NASHVILLE TN 37201
• ·Phone: 833-267-3235

23-03-2026

Verde Clean Fuels, Inc. appointed George Burdette, its current CFO since October 2024, as new CEO, succeeding Ernie Miller who is stepping down to pursue other opportunities but will remain as a senior advisor. The company engaged Roth Capital Partners as a financial advisor to evaluate strategic alternatives, including potential merger, sale, or other transactions involving its STG+® technology, as part of ongoing restructuring and cost reduction initiatives. While positioned as a step to maximize shareholder value through capital-lite opportunities, the process has no set timetable and no assurance of any transaction.

• ·George Burdette previously served as CFO of Arbor Renewable Gas and Itafos, and head of project finance at First Solar.
• ·No binding agreements entered for strategic alternatives; company does not intend to disclose developments unless required.
• ·Announcement dated March 20, 2026; SEC filing March 23, 2026.

23-03-2026

Faraday Future Intelligent Electric Inc. announced that the SEC has concluded its years-long investigation into 2021 PIPE and SPAC-related transactions with no enforcement action against the Company, founder and Co-CEO YT Jia, President Jerry Wang, or other team members, removing a major regulatory overhang. This provides clarity to pursue strategic financing, partnerships, Nasdaq compliance within 180 days without a reverse split, and focus on EAI vehicles and robotics. However, forward-looking statements highlight ongoing risks including liquidity shortages, potential delisting if share price falls below $0.10 for 10 days, substantial dilution needs, and execution challenges on vehicle deliveries and robotics.

• ·Nasdaq compliance notice received March 20, 2026, granting 180-day period to meet $1 minimum bid price without reverse stock split.
• ·SEC investigation originated from independent director probe in October 2021 related to SPAC merger.
• ·FF 91 deliveries began in 2023; Super One deliveries planned for 2026; Embodied AI Robotics sales beginning in 2026.

23-03-2026

KKR & Co. Inc. filed Definitive Additional Proxy Materials (DEFA14A) on March 23, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No substantive financial or operational details are provided in the available filing header.

• ·Filing categorized as Definitive Additional Materials under Schedule 14A.
• ·No fee required for the filing.

23-03-2026

On March 19, 2026, Barnwell Industries, Inc. issued a press release highlighting its Canadian oil production assets in light of recent increases in global energy prices. The release also provides an update on the Company's ongoing evaluation of strategic alternatives for those assets. The 8-K was filed on March 23, 2026, with the press release attached as Exhibit 99.1.

23-03-2026

Hubbell Incorporated filed its DEF 14A definitive proxy statement on March 23, 2026, for the 2026 Annual Meeting of Shareholders on May 5, 2026, at 9:00 a.m. in Shelton, CT. Items include election of directors (Board recommends FOR all nominees), advisory vote to approve Named Executive Officer compensation (FOR), and ratification of PricewaterhouseCoopers LLP as independent auditors for 2026 (FOR). The record date is March 6, 2026; no financial performance metrics or compensation amounts are detailed in the provided content.

• ·Fiscal year end: December 31
• ·Record date: March 6, 2026
• ·Meeting location: 40 Waterview Drive, Shelton, CT 06484
• ·Proxy materials available online at www.proxyvote.com

23-03-2026

Mobilicom Ltd filed its 20-F Annual Report on March 23, 2026, disclosing various material risks including the need for substantial additional capital to achieve profitability, potential shortfalls in external R&D funding, challenges in revenue forecasting, exchange rate fluctuations, and negative customer perceptions that could adversely impact operations and cash flows. The company outlined a key growth strategy centered on increasing design wins and pilot projects to enhance market penetration, deepen customer relationships, and drive future revenue through cross-selling and regulatory certifications. However, it anticipates incurring significant R&D costs for new products and faces uncertainties in monetizing cloud-based software, cybersecurity solutions, and acquired technologies.

• ·20-F filing includes sections on share capital, material contracts, taxation, market risk disclosures, controls and procedures, audit committee financial expert, code of ethics, principal accountant fees, and cybersecurity.
• ·ITEM 17 and ITEM 18 reference financial statements.

23-03-2026

On March 20, 2026, Robert W. Dudley, a member of the Board of Directors of Freeport-McMoRan Inc., notified the Lead Independent Director and Chairman that he will not stand for re-election at the company's 2026 annual meeting of stockholders. Mr. Dudley will continue serving the remainder of his current term, which ends at that meeting. The decision was explicitly stated not to be due to any disagreement with the company.

23-03-2026

General Motors Company and General Motors Financial Company, Inc. entered into the Eighth Amended and Restated 364-Day Revolving Credit Agreement dated March 23, 2026, amending and restating the prior Seventh Amended and Restated agreement from March 25, 2025. The facility involves multiple lenders, with JPMorgan Chase Bank, N.A. as Administrative Agent and Citibank, N.A. as Syndication Agent, along with various joint lead arrangers and bookrunners. No specific commitment amounts, pricing grids, or changes in terms are detailed in the filing excerpt.

• ·Filing Type: 8-K, Items: 1.01, 2.03, 9.01
• ·Previous credit agreement effective date: March 25, 2025
• ·Schedules include Commitments (1.1A), Applicable Pricing Grid (1.1C), but details redacted or not provided

23-03-2026

Molina Healthcare's 2026 proxy statement solicits votes for electing ten directors (including new nominee Francis S. Soistman), advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as 2026 auditors, amendment to the 2025 Equity Incentive Plan to increase shares, and amendment to the Certificate of Incorporation allowing stockholders to call special meetings. The company reports serving 5.5 million members across 21 states as of December 31, 2025, with growth via new Medicaid/Medicare contracts in states like Idaho, Michigan, Massachusetts, Ohio, Wisconsin, Nevada, Illinois, Florida Kids (120,000 enrollees), Mississippi, and a $350M acquisition of ConnectiCare adding 140,000 members; however, it lost the Virginia Medicaid contract, terminating June 30, 2025.

• ·Annual meeting date: May 6, 2026, 10:00 a.m. ET, virtual at www.virtualshareholdermeeting.com/MOH2026
• ·Record date: March 9, 2026
• ·Filing date: March 23, 2026
• ·ConnectiCare acquisition closed February 1, 2025
• ·Nevada contract: January 1, 2026 to December 31, 2030, with one two-year extension
• ·Illinois contract: initial four years from January 1, 2026, up to ten years total
• ·Florida Kids contract expected through December 31, 2030
• ·Florida Medicaid contract (July 2024 award): February 1, 2025 to December 31, 2030
• ·Wisconsin contracts: two years from January 1, 2026/2025, with three two-year extensions possible

23-03-2026

General Motors Company and General Motors Financial Company, Inc. entered into the Eighth Amended and Restated 364-Day Revolving Credit Agreement dated March 23, 2026, amending and restating the prior Seventh Amended and Restated agreement from March 25, 2025. The facility involves multiple lenders led by JPMorgan Chase Bank, N.A. as Administrative Agent and Citibank, N.A. as Syndication Agent, with terms including commitments detailed in Schedule 1.1A (not specified in excerpt) and standard covenants such as minimum liquidity and indebtedness restrictions. No quantitative changes or performance metrics are disclosed in the filing.

• ·Agreement replaces Seventh Amended and Restated 364-Day Revolving Credit Agreement dated March 25, 2025.
• ·References related facilities: Sixth Amended and Restated Three Year Revolving Credit Agreement and Fifth Amended and Restated Five Year Revolving Credit Agreement, both dated March 25, 2025.
• ·Covenants include Minimum Liquidity (Section 7.1), Indebtedness limits (Section 7.2), and Asset Sale Restrictions (Section 7.3).

23-03-2026

On March 23, 2026, Limoneira Company announced that its Board of Directors paused regular cash dividends on common stock to prioritize capital investments in transitioning agriculture lands to higher-value avocado production and developing new housing. While this supports long-term growth through expected incremental cash flow improvements, it represents a short-term negative for dividend-seeking shareholders. The Board plans to resume dividends aligned with historical practice when prudent.

23-03-2026

Coca-Cola Consolidated, Inc. (COKE) filed Definitive Additional Proxy Materials (DEFA14A) on March 23, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is categorized as Definitive Additional Materials for proxy solicitation. No financial metrics, performance data, or specific proposals are detailed in the provided filing header.

• ·Filed by the Registrant.
• ·Not filed by a party other than the Registrant.

23-03-2026

Comtech Telecommunications Corp. filed a Form S-3 shelf registration statement with the SEC on March 23, 2026, enabling the potential offering of up to $125 million in common stock, preferred stock, debt securities, warrants, purchase contracts, or units from time to time based on market conditions. The company's common stock (CMTL) had a last reported sale price of $3.66 per share on March 17, 2026, and trades on the Nasdaq Global Select Market. As a smaller reporting company, Comtech qualifies due to non-affiliate market value under $250M or annual revenue under $100M, allowing reduced disclosure obligations.

• ·Principal executive offices: 305 N 54th Street, Chandler, Arizona 85226; Phone: (480) 333-2200
• ·Incorporated in Delaware; I.R.S. Employer Identification Number: 11-2139466; Founded: 1967
• ·Reportable segments: Allerium (formerly Terrestrial and Wireless Networks) and Satellite and Space Communications

23-03-2026

Diamond Hill Funds filed definitive additional proxy materials (DEFA14A) on March 23, 2026, as part of an upcoming acquisition, urging shareholders to vote via proxy solicitation efforts led by Sodali & Co., who are contacting non-voting shareholders by phone, email, and mail. The communication highlights issues with 'master accounts' where proxy materials may go to firms rather than individual clients, potentially requiring firm-level voting. No financial metrics or performance data are disclosed in this procedural update.

• ·Fiscal year end: December 31
• ·Business address: 325 John H. McConnell Boulevard, Suite 200, Columbus, OH 43215
• ·Business phone: 614-255-3333

23-03-2026

United States Antimony Corp reported FY2025 revenues of $39.3M, up 163% YoY, driven by antimony price increases and zeolite volume/price gains, with gross profit surging 185% to achieve 25% margins from 23%. However, net loss widened to $4.3M from $1.7M in FY2024 due to $6.7M in non-cash expenses primarily from stock compensation. The company secured $354M in 5-year contracts, boosted cash to $91.3M, and advanced acquisitions like the Fostung tungsten property with >$4.6B inferred resources and Larvotto Resources stake for $37.2M.

• ·17% of FY2025-end antimony inventory from company-owned Montana mine
• ·Madero smelter capacity: 200 tons/month of antimony material
• ·Stibnite Hill ore: 800 tons grading 10% antimony
• ·Nolan Creek reserves: 42,400 tons at 28% antimony and 0.408 oz gold/ton
• ·MK copper deposit samples average 16.5% copper, 2.2 oz silver, 0.08 oz gold/ton

23-03-2026

Intel Corporation (INTC) filed a DEFA14A Definitive Additional Materials on March 23, 2026, as part of its proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing, titled 'a2026noticeaccess.htm', appears to be a notice of internet availability of proxy materials and indicates no filing fee required. No financial metrics, performance data, or other substantive details are provided in the filing header.

• ·Filing categorized as Definitive Additional Materials (not Preliminary Proxy Statement or Soliciting Material).

23-03-2026

Element Solutions Inc announced that Sir Martin E. Franklin, Executive Chairman of the Board, plans to step down and will not seek re-election at the 2026 Annual Meeting of Stockholders. Ian G.H. Ashken, a founding Board director since 2013 and Chair of the Nominating and Policies Committee, has been appointed Non-Executive Chairman effective at the Annual Meeting. Franklin will remain a substantial shareholder and continue as a counselor to CEO Ben Gliklich.

• ·Announcement dated March 23, 2026
• ·Ashken has been a founding director since 2013
• ·Franklin has partnered with CEO Gliklich for more than 12 years

23-03-2026

Isabella Bank Corporation's DEF 14A proxy statement for the 2026 Annual Meeting on May 5, 2026, at 10:00 a.m. EDT proposes electing five director nominees (four to serve until the 2029 annual meeting and one until 2027), an advisory vote to approve named executive officer compensation, approval of the 2025 Employee Stock Purchase Plan, and ratification of Plante & Moran, PLLC as independent auditors for the year ending December 31, 2026. The record date is March 13, 2026, with 7,330,036 shares of common stock outstanding, and the meeting will be held virtually via www.virtualshareholdermeeting.com/ISBA2026. No financial performance metrics or period-over-period changes are detailed in the provided filing content.

• ·Annual Meeting held solely by remote communication; no in-person attendance.
• ·Shareholders must use individually-assigned participant code from proxy card to access virtual platform.
• ·Proxy materials available at www.proxyvote.com and isabellabank.com Investor Relations section, including 2025 Annual Report and Form 10-K for year ended December 31, 2025.

23-03-2026

On March 18, 2026, Intelligent Bio Solutions Inc. granted time-vesting restricted stock awards of 9,150 shares each to CEO Harry Simeonidis and CFO Spiro Sakiris (vesting after 48 months), plus performance-vesting awards of 21,350 shares each tied to clinical, regulatory, and commercial milestones; non-employee directors received an aggregate 20,000 time-vesting shares (vesting after 12 months), and non-executive employees received 10,500 time-vesting and 24,500 performance-vesting shares. As of March 23, 2026, the company had 2,001,173 shares of common stock outstanding following these grants and warrant exercises. The company also filed a 2026 ATM Supplement enabling up to $3.97M in additional common stock sales under its existing ATM Agreement.

• ·Performance-vesting shares subject to milestones: 30% upon clinical trial achievement (post-1 year), 40% upon FDA regulatory submission (post-1 year), 30% upon commercial supply/sales milestone (post-1 year); unachieved portions forfeit after 10 years.
• ·Awards include dividend rights on unvested shares (paid upon vesting) and are subject to clawback policy.
• ·ATM Agreement originally dated September 18, 2024; Registration Statement effective September 10, 2025 (File No. 333-286489).

23-03-2026

Aspen Aerogels reported a sharp revenue decline of 40% YoY to $271.1M in 2025 from $452.7M in 2024, driven by drops in both U.S. (33% decline to $172.1M) and international sales, alongside segment weaknesses in Energy Industrial (down 30% to $102.2M) and Thermal Barrier (down 45% to $168.9M). The company swung to a massive net loss of $389.6M from a $13.4M profit, primarily due to a $291.2M impairment of property, plant, and equipment, $17.5M restructuring costs, and $18.2M loss on disposal, resulting in total assets shrinking 55% to $406.7M and stockholders' equity falling 62% to $235.5M. Cash and equivalents decreased to $156.9M from $220.9M, though operating cash flow remained positive at $32.9M.

• ·Accounts receivable net decreased to $35.3M from $109.1M, with allowances rising to $4.2M from $1.3M.
• ·Capital expenditures reduced to $37.4M in 2025 from $86.3M in 2024.
• ·Interest paid increased to $12.2M in 2025 from $7.0M in 2024.

23-03-2026

For the six months ended January 31, 2026, Concrete Leveling Systems Inc reported revenue of $55,150, a massive 17,913% YoY increase from $308, swinging to net income of $862 from a $37,499 loss, driven by higher sales and operational income of $5,365. However, the three months ended January 31 showed revenue growth of 20% to $150 but a widened net loss of $15,817 from $12,696 YoY due to elevated operating expenses of $13,704. Cash improved significantly to $19,749 from $824 at July 31, 2025, though current liabilities rose to $662,730 amid heavy related-party debt.

• ·Gross margin for six months ended Jan 31, 2026: $54,089 (98% of sales) vs $239 prior year.
• ·Operating expenses for three months: $13,704 in 2026 vs $10,227 in 2025, driven by legal fees $11,310 vs $7,450.
• ·Net cash from operating activities six months: $20,059 in 2026 vs used $210 in 2025.
• ·Purchase of PPE: $1,134 in six months ended Jan 31, 2026.
• ·Accrued interest - stockholders: $60,918 as of Jan 31, 2026 vs $56,416 at July 31, 2025.

23-03-2026

BlackRock, Inc. (BLK) filed a DEFA14A additional proxy statement on March 23, 2026, referencing its Form 10-K for the year ended December 31, 2025, filed on February 25, 2026. The filing notes that changes in securities holdings since the 2025 Proxy Statement will be reported on Form 4 filings and urges shareholders to review the 2026 Proxy Statement (including amendments), 2025 Proxy Statement, Form 10-K, and other relevant SEC documents. Documents are available free of charge via SEC.gov, https://ir.blackrock.com, or by request to the Company's Secretary at 50 Hudson Yards, New York, New York 10001.

23-03-2026

Harmonic Inc. entered into an Asset Purchase Agreement dated March 20, 2026, with Leone Media Inc. to sell its video business assets, including Identified Products and Services, and equity interests in Acquired Subsidiaries (Harmonic International GmbH, Financiere Kepler SAS, and Harmonic Video Networks Ltd.), while assuming certain Assumed Liabilities. The deal follows the exercise of a put option agreement dated December 8, 2025, on March 16, 2026, after works council consultation in France. No purchase price or financial terms are disclosed in the filing.

• ·Balance Sheet Date: September 30, 2025
• ·Business excludes Harmonic's broadband business
• ·Ancillary Agreements include Intellectual Property Assignment, Transition Services Agreement, and Equity Commitment Letter

23-03-2026

TPG Private Equity Opportunities, L.P. (T-POP) reported a net increase in net assets from operations of $135.2M for the year ended December 31, 2025, driven by $170M in unrealized gains on investments, with total net assets reaching $1.02B from $0 in 2024 following $897M in unit issuance proceeds. However, the fund recorded a net investment loss of $33.0M as total expenses of $35.5M significantly exceeded revenues of $2.6M, and cash balances remained at $0 despite offsetting operating and financing cash flows. NAV per unit increased across classes, delivering total returns of 18.7% to 24.5%.

• ·Cash and cash equivalents remained at $0 at period end.
• ·Deconsolidation of T-POP US Aggregator (CYM), L.P. impacted changes by $(2.6M).
• ·Organizational expenses: $7.4M; Performance Participation Allocation: $19.3M.
• ·T-POP US Aggregator commenced operations June 2, 2025.

23-03-2026

On March 19, 2026, Portsmouth Square, Inc. dismissed WithumSmith+Brown, PC as its independent registered public accounting firm effective immediately and appointed Whitley Penn LLP as the new firm, subject to standard acceptance procedures, for the fiscal year ending June 30, 2026. There were no disagreements on accounting principles, financial disclosures, auditing scope, or reportable events with Withum during fiscal years ended June 30, 2025 and 2024, or the subsequent interim period through March 19, 2026. Withum provided a letter dated March 23, 2026, agreeing with these statements, filed as Exhibit 16.1.

• ·Fiscal years reviewed: ended June 30, 2025 and 2024, plus interim through March 19, 2026
• ·New engagement covers fiscal year ending June 30, 2026 and related interim periods
• ·No prior consultations with Whitley on accounting, auditing, or reporting matters

23-03-2026

The 10-K filing for JPMBB Commercial Mortgage Securities Trust 2014-C18 includes servicing criteria compliance assertions under Regulation AB Item 1122 by servicer Midland and other asserting parties, confirming adherence to most applicable criteria such as policies for monitoring defaults, cash handling, reconciliations, and loss mitigation. Several criteria are marked N/A due to transaction agreement specifics or lack of applicability, with some activities performed by vendors under responsible party oversight. No material deficiencies or exceptions to compliance are reported.

• ·Filing date: March 23, 2026
• ·Multiple servicing criteria marked N/A, including back-up servicer maintenance, investor remittances, and external enhancements
• ·Certain criteria applicable only to 'Platform A' (e.g., Commission filing and record agreement), not 'Platform B'

23-03-2026

Artelo Biosciences, Inc. (ARTL) filed an S-1/A registration statement on March 23, 2026, for a public offering of common stock and pre-funded warrants, with Craft Capital Management LLC as placement agent receiving 8.0% fees and warrants equal to 8.0% of securities sold. Interim Phase 2a CAReS trial results for ART27.13 showed mean body weight gain of 6.38% (n=5 at top dose) versus -5.42% loss in placebo (n=6), with lean body mass +4.23% vs -3.15%, and a favorable safety profile among 32 enrolled patients. Phase 1 SAD study for ART26.12 in 49 healthy subjects reported no drug-related adverse events and linear pharmacokinetics.

• ·ART27.13 daily dose approved up to 1,300 micrograms; CAReS initiated Phase 2a in April 2023 across 18 sites in 5 countries.
• ·ART26.12 IND cleared by FDA in July 2024; Phase 1 results announced June 2025.
• ·ART12.11 composition of matter patent enforceable until December 10, 2038, granted/validated in 21 countries.
• ·Interim CAReS analysis announced September 3, 2025; all AEs mild/moderate except one severe malaise, no serious drug-related AEs.

23-03-2026

On March 23, 2026, Adam Peterson resigned from Nelnet, Inc.'s Board of Directors effective immediately for business and personal reasons, not due to any disagreement with the company's operations, policies, or practices. The Board and management expressed appreciation for his dedicated service and significant contributions during his tenure.

• ·Resignation notified on March 23, 2026, and effective immediately.
• ·Company headquartered at 121 South 13th Street, Suite 100, Lincoln, Nebraska 68508.

23-03-2026

The 10-K annual report for GS Mortgage Securities Trust 2019-GSA1, filed on March 23, 2026, details compliance assertions by servicers including Midland, Special Servicer, and PBLS with applicable Regulation AB 1122(d) servicing criteria. Most relevant criteria are affirmed as performed directly or by responsible vendors, while many others are designated N/A or inapplicable depending on the servicer's specific role, with no material non-compliance or deficiencies reported. Standard timeframes such as 2 business days for deposits/postings and 30-90 calendar days for reconciliations remain unchanged from prior requirements.

• ·Multiple criteria marked N/A or inapplicable for certain servicers (e.g., back-up servicer maintenance, investor remittances for Special Servicer)
• ·Platform A applicable for some reporting criteria; Platform B not applicable

23-03-2026

BBCMS Mortgage Trust 2020-C6 filed its 10-K annual report on March 23, 2026, containing Regulation AB Item 1122 servicing compliance assertions from servicers Midland, K-Star, KeyBank, and PBLS. The assertions show that most applicable servicing criteria were performed directly by the servicers or by vendors for which they are responsible, while several criteria (e.g., back-up servicer maintenance, investor remittances) were marked N/A or not performed by certain servicers. No material non-compliance or deficiencies were identified across the reviewed criteria.

23-03-2026

The 10-K filing for JPMBB Commercial Mortgage Securities Trust 2015-C27, dated March 23, 2026, provides servicing compliance assertions under Regulation AB Item 1122(d) for servicer Midland and other asserting parties. Most applicable criteria are marked as performed directly by Midland or via responsible vendors, while many others are designated N/A due to inapplicability to their roles; no material noncompliance or exceptions are noted. Investor reporting and loss mitigation criteria are confirmed applicable and compliant where relevant.

23-03-2026

23-03-2026

Moleculin Biotech, Inc. (MBRX) announced the enrollment of the 45th subject in its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) for relapsed or refractory acute myeloid leukemia (R/R AML). This milestone triggers the final phase of preparation for the interim unblinding of data from these 45 subjects, which remains on track for mid-2026 and is described as a potentially defining inflection point for the company. No negative developments or delays were reported.

• ·Trial targets adult subjects with relapsed or refractory acute myeloid leukemia (R/R AML)
• ·Interim data unblinding on track for mid-2026

23-03-2026

Reliance Global Group, Inc. filed a DEF 14A proxy statement on March 23, 2026, proposing the election of five directors—Ezra Beyman, Alex Blumenfrucht, Scott Korman, Ben Fruchtzweig, and Sheldon Brickman—for a one-year term expiring at the 2027 Annual Meeting. The company engaged Laurel Hill for proxy solicitation services at a cost of $7,000 plus expenses, with costs borne by the company and no additional compensation for officers or directors assisting in solicitation. No financial performance metrics, period-over-period comparisons, or other proposals are detailed in the filing.

• ·Principal executive offices located at 300 Blvd. of the Americas, Suite 105, Lakewood, NJ 08701.
• ·Contact for questions: Joel Markovits at (732) 380-4646 or jmarkovits@relianceglobalgroup.com.
• ·Annual Meeting voting results to be announced within four business days after the meeting.
• ·No right of appraisal for dissenting stockholders.

23-03-2026

Kimberly-Clark reported 2025 net sales of $16.4 billion, down 2.1% YoY despite 1.7% organic sales growth, with operating profit declining to $2.4 billion from $2.7 billion though adjusted operating profit held steady at $2.7 billion; diluted EPS fell to $6.07 from $7.55 but adjusted EPS rose to $7.53 from $7.30. The proxy highlights strategic moves including a JV with Suzano for the International Family Care & Professional business (retaining 49% interest, closing mid-2026) and acquisition of Kenvue to create a $32 billion entity (closing H2 2026, approved Jan 2026), alongside a $2 billion North America supply chain investment. Segment sales showed North America at $10.8 billion, International Personal Care at $5.7 billion, and IFP (discontinued) at $3.3 billion.

• ·54th consecutive year of quarterly dividend increase
• ·Annual stockholder meeting: May 14, 2026, 8:00 a.m. Central Time, virtual at https://meetnow.global/MUAPH5P
• ·Record date: March 16, 2026
• ·Board nominees: 13 total, 12 independent, median tenure 6.0 years, 7 female, 5 ethnically diverse
• ·Suzano JV announcement: June 2025; Kenvue agreement: November 2025; Kenvue stockholder approval: January 2026
• ·Expected to impact 24 million women and girls via Foundation NGO partnerships over next 3 years